Glenmark Pharmaceuticals Inc., USA recalls

6 recalls.

• Abiraterone Acetate Tablets USP 500 mg recall (Glenmark Pharmaceuticals Inc., USA)
  DrugClass IIReported November 4, 2026 · Labeling: Not Elsewhere Classified
• Azelaic Acid Gel recall (Glenmark Pharmaceuticals Inc., USA)
  DrugClass IIReported August 5, 2026 · CGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.
• Alyacen 7/7/7 recall (Glenmark Pharmaceuticals Inc., USA)
  DrugClass IIReported June 24, 2026 · Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
• Ondansetron Orally Disintegrating Tablets recall (Glenmark Pharmaceuticals Inc., USA)
  DrugClass IIReported January 7, 2026 · Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets...
• Nebivolol Tablets recall (Glenmark Pharmaceuticals Inc., USA)
  DrugClass IIIReported December 17, 2025 · Cross Contamination with Other Products
• Bisoprolol Fumarate and Hydrochlorothiazide Tablets recall (Glenmark Pharmaceuticals Inc., USA)
  DrugClass IIIReported December 10, 2025 · Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe